Acasti Pharma Inc
NASDAQ: ACST
$2.93
Closing price April 25, 2024
Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that blocked its patents on the medication Vascepa, the company’s chief executive says....
Published: